Form D Explorer
Cyrus Biotechnology, Inc. · CIK 1641241

Report a data issueCitable research briefCompare issuerPrivate research collection

Cyrus Biotechnology, Inc.

CIK 1641241 · Corporation · Inc. DELAWARE · SEATTLE, Washington · Biotechnology
Filings
2
Original notices
1
Amendments
1
Activity
Jul 16, 2025
through May 8, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJul 16, 2025 · DMay 8, 2026 · D/ALater minus earlier
Reported offering amount$1,500,000$3,000,000$1,500,000
Reported amount sold$1,110,000$1,481,812$371,812
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001641241-25-000003 · Later SEC source: 0001641241-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D/A · May 8, 2026

Reported offering amount
$3,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$1,481,812

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)